Cell line · CVCL_0186
BxPC-3
Cancer cell line, Homo sapiens. Pancreatic ductal adenocarcinoma. 216 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. BxPC-3. Cell lines, record CVCL_0186. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0186
On this page
Cell line
As Cellosaurus gives it.
- Name
- BxPC-3
- Accession
- CVCL_0186
- RRID
- RRID:CVCL_0186
- Synonyms
- BxPc-3, BXPC-3, Bx-PC3, BXPC3, BxPC3, BxPc3, Biopsy xenograft of Pancreatic Carcinoma line-3
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 61Y
- Category
- Cancer cell line
- Diseases
- Pancreatic ductal adenocarcinoma (NCIt C9120)
- Derived from
- Pancreas (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | Additional TP53 mutation in c.793C>T indicated incorrectly in PubMed=1630814. |
Source Cellosaurus
Papers216
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Pharmacokinetic Tuning Redirects β‐Lapachone From NQO1 Bioactivation to Vimentin‐Targeted Oxidation in Cancer | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Engineered αvβ6-targeting peptide‒BSH conjugates for boron neutron capture therapy of pancreatic ductal adenocarcinoma. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting SERPINB5 and MSLN for Pancreatic Cancer Therapy. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Therapeutic Efficacy and Safety of Intraperitoneally Administered 211At-Labeled Gold Nanoparticles for Peritoneally Disseminated Malignancies. | Pharmaceutics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CPT1A through succinylation regulates the CTCF/LINC01503‒91aa feedback loop to promote gemcitabine resistance in pancreatic ductal adenocarcinoma. | Clin Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Systematic Targeting of Protein Complexes with Molecular COUPLrs. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting CD24 Activates Macrophages to Reduce Tumor Burden in Preclinical Models of Solid Tumors. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Early induction of the Rho-GEF ECT2 drives MEK/ERK oncogenic signaling in pancreatic ductal adenocarcinoma. | Oncogene | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 216
See all 216 papersRelatives29
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | BXPC-3/Cas9-hyg | CVCL_C9DP | Cell lines | |
| Derived from it | Bx-GEM50 | CVCL_E4NF | Cell lines | |
| Derived from it | BxPC-3 SMAD2 KO | CVCL_E2X4 | Cell lines | |
| Derived from it | BxPC-3 SMAD2/SMAD3 DKO | CVCL_E2X5 | Cell lines | |
| Derived from it | BxPC-3 SMAD3 KO | CVCL_E2X6 | Cell lines | |
| Derived from it | BxPC-3 XL-1 | CVCL_E4N8 | Cell lines | |
| Derived from it | BxPC-3 human CCR5 | CVCL_E8JC | Cell lines | |
| Derived from it | BxPC-3 human CLDN18.2 | CVCL_XZ31 | Cell lines | |
| Derived from it | BxPC-3 human GPRC5D | CVCL_E8JD | Cell lines | |
| Derived from it | BxPC-3 human GPRC5D-HA | CVCL_E8JB | Cell lines |
1 to 10 of 29
See all 29 relativesCell banks12
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1687 | ATCC | |
| AddexBio | C0018003/27 | Cellosaurus | |
| BCRC | 60283 | BCRC | |
| BCRJ | 0056 | BCRJ | |
| CLS | 305031 | CLS | |
| DSMZ | ACC-760 | DSMZ | |
| ECACC | 93120816 | ECACC | |
| EDITGENE | EDC00328 | EDITGENE | |
| ICLC | HTL96011 | ICLC | |
| IZSLER | BS TCL 4 | Cellosaurus |
1 to 10 of 12
See all 12 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0186
GET https://conductscience.org/api/cell-lines/v1/CVCL_0186/papers?page=2